Holen Sie sich die Stockscreener-App
8.51
2.89%
-0.34
Aspire Biopharma Holdings Inc Aktie (ASBP) Neueste Nachrichten
Aspire-Lakewood Holdings Board Approves $10 Million Share Repurchase Program - finance.yahoo.com
Aspire BioPharma, Inc. (NASDAQ: ASBP) Share Price, ASBP Stock News, ASBP Share Price & Updates - Kalkine
Aspire Biopharma Changes Name to Aspire-Lakewood Holdings - Minichart
Aspire Biopharma Announces Corporate Name Change To Aspire-Lakewood Holdings - TradingView
Aspire Bi changes corporate name to Aspire-Lakewood Holdings; ticker ASBP unchanged - TradingView
Aspire Biopharma changes name to Aspire-Lakewood Holdings By Investing.com - Investing.com Canada
Aspire Biopharma changes name to Aspire-Lakewood Holdings - Investing.com
Aspire Biopharma Holdings, INC. Announces Corporate Name Change To Aspire-Lakewood Holdings, Inc. - ACCESS Newswire
ASBPAspire Biopharma Holdings Inc Volatility & Greeks - Finviz
Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution - DelmarvaNow.com
Form 8K Aspire Biopharma Holdings Inc For: 19 August By Investing.com - Investing.com Nigeria
ASBP Stock Back On Retail Radar After 78% Crash – Bulls Eye $1 Comeback - Stocktwits
LCID, ASBP, WLDS Stocks Hit 52-Week Lows: What Drove The Selloff? - Stocktwits
Aspire Biopharma (ASBP) Holds Steady at $7.91 with Key Support and Resistance in FocusParabolic SAR - vinanet.vn
Aspire (ASBPW) Retreats -0.54% — Bears Take Control Below $0.02 2026-08-17Arms Index - vinanet.vn
Aspire Biopharma Completes Acquisition of Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue - ACCESS Newswire
S&R Associates Advises MiddleGround Capital on Sale of Dura Driver Control Systems to Aspire Biopharma Holdings - SCC Online
Aspire Biopharma (NASDAQ: ASBP) slashes H1 2026 loss and rebuilds equity - Stock Titan
Aspire Biopharma Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Aspire Biopharma (ASBP) Gains 1.82% to $7.26, Approaches Key Resistance ZoneBackspread Trade - vinanet.vn
Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th - ACCESS Newswire
Aspire Biopharma (ASBPW) Warrant Rises 5.00% to $0.02, Trapped in Tight Trading RangeAccumulation Line - vinanet.vn
S&R Associates represented MiddleGround Capital - Lexology
ASBP Stock Heads For Best Week In Over 2 Months – Why This Drug Delivery Tech Firm Is Buying An Auto Supplier? - Stocktwits
Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin - The Public Opinion
EXCLUSIVE: Aspire Biopharma Buys Its Way Into Global Auto Market With $30 Million DCS Deal - Yahoo Finance
Form 8K Aspire Biopharma Holdings Inc For: 10 August By Investing.com - Investing.com Nigeria
Aspire Biopharma Completes $30 Million Acquisition of Dura Driver Control Systems - citybiz
Aspire Biopharma Closes Acquisition of FireFish Units Under Asset and Equity Purchase Agreement - TradingView
Aspire Biopharma completes $30M automotive supplier acquisition By Investing.com - Investing.com Australia
Aspire Biopharma completes $30M automotive supplier acquisition - Investing.com
Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack - The Northwest Florida Daily News
Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance With Continued Listing Requirements - news.futunn.com
Aspire Biopharma (ASBP) Climbs 3.3% to $7.27, Approaches Key Resistance at $7.63Sector Sentiment - vinanet.vn
Aspire Biopharma Announces Signing of Definitive Share Purchase Agreement to Acquire Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue - ACCESS Newswire
Aspire Biopharma Holdings Inc (ASBP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aspire Biopharma Holdings Inc (ASBP) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aspire Biopharma Holdings Inc (ASBP) Cash Flow - TradingKey
Aspire Biopharma Holdings Inc (ASBP) Income Statement - TradingKey
Aspire Biopharma Holdings Inc (ASBP) Institutional Confidence - TradingKey
Aspire Biopharma Holdings Inc (ASBP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aspire Biopharma Holdings, Inc. Revenue Breakdown – NASDAQ:ASBPW - TradingView
TradingKey - TradingKey
ASBP|Aspire Biopharma Holdings Inc|Price:7.150|Chg%:-0.110 - TradingKey
Aspire Biopharma Holdings Inc (ASBP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aspire Biopharma Holdings Inc (ASBP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aspire Biopharma Holdings Inc (ASBP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aspire Biopharma Holdings (ASBP) Edges Higher Near Key Support LevelMerger Arbitrage - vinanet.vn
Aspire Biopharma Holdings, Inc. Revenue Breakdown – NASDAQ:ASBP - TradingView
Aspire Biopharma (ASBP) Edges Higher as Stock Approaches Key Resistance LevelMFI Oversold - Vinanet
ASBP|Aspire Biopharma Holdings Inc|Price:7.260|Chg%:+0.050 - TradingKey
Enterprise value to revenue forward of Aspire Biopharma Holdings, Inc. – NASDAQ:ASBP - TradingView
0.29%
4.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):